KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
JOURNAL OF CLINICAL ONCOLOGY, vol.41, no.16, 2023 (SCI-Expanded, Scopus)
- Publication Type: Article / Abstract
- Volume: 41 Issue: 16
- Publication Date: 2023
- Journal Name: JOURNAL OF CLINICAL ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
- Ankara University Affiliated: Yes